These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2542557)

  • 1. Folate analogues. 32. Synthesis and biological evaluation of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid and related compounds.
    Patil SD; Jones C; Nair MG; Galivan J; Maley F; Kisliuk RL; Gaumont Y; Duch D; Ferone R
    J Med Chem; 1989 Jun; 32(6):1284-9. PubMed ID: 2542557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate analogues. 35. Synthesis and biological evaluation of 1-deaza, 3-deaza, and bridge-elongated analogues of N10-propargyl-5,8-dideazafolic acid.
    Li SW; Nair MG; Edwards DM; Kisliuk RL; Gaumont Y; Dev IK; Duch DS; Humphreys J; Smith GK; Ferone R
    J Med Chem; 1991 Sep; 34(9):2746-54. PubMed ID: 1895294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate analogues. 26. Syntheses and antifolate activity of 10-substituted derivatives of 5,8-dideazafolic acid and of the poly-gamma-glutamyl metabolites of N10-propargyl-5,8-dideazafolic acid (PDDF).
    Nair MG; Nanavati NT; Nair IG; Kisliuk RL; Gaumont Y; Hsiao MC; Kalman TI
    J Med Chem; 1986 Sep; 29(9):1754-60. PubMed ID: 3091832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate analogues. 30. Synthesis and biological evaluation of N10-propargyl-5,8-dideaza-5,6,7,8-tetrahydrofolic acid and related compounds.
    Nair MG; Dhawan R; Ghazala M; Kalman TI; Ferone R; Gaumont Y; Kisliuk RL
    J Med Chem; 1987 Jul; 30(7):1256-61. PubMed ID: 3599032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate analogues. 25. Synthesis and biological evaluation of N10-propargylfolic acid and its reduced derivatives.
    Ghazala M; Nair MG; Toghiyani TR; Kisliuk RL; Gaumont Y; Kalman TI
    J Med Chem; 1986 Jul; 29(7):1263-9. PubMed ID: 3100797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.
    Cheng YC; Dutschman GE; Starnes MC; Fisher MH; Nanavathi NT; Nair MG
    Cancer Res; 1985 Feb; 45(2):598-600. PubMed ID: 3917852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate analogues altered in the C9-N10 bridge region: N10-Toxylisohomofolic acid and N10-Toxylisohomoaminopterin.
    Nair MG; O'Neal PC; Baugh CM; Kisliuk RL; Gaumont Y; Rodman M
    J Med Chem; 1978 Jul; 21(7):673-7. PubMed ID: 97383
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts.
    Hynes JB; Patil SA; Hagan RL; Cole A; Kohler W; Freisheim JH
    J Med Chem; 1989 Apr; 32(4):852-6. PubMed ID: 2704031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.
    Jackman AL; Marsham PR; Thornton TJ; Bishop JA; O'Connor BM; Hughes LR; Calvert AH; Jones TR
    J Med Chem; 1990 Nov; 33(11):3067-71. PubMed ID: 2231607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors.
    Jansen G; Schornagel JH; Westerhof GR; Rijksen G; Newell DR; Jackman AL
    Cancer Res; 1990 Dec; 50(23):7544-8. PubMed ID: 2253202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modifications.
    Jones TR; Smithers MJ; Taylor MA; Jackman AL; Calvert AH; Harland SJ; Harrap KR
    J Med Chem; 1986 Apr; 29(4):468-72. PubMed ID: 3754284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
    Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
    Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
    Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antifolate evaluation of the 10-propargyl derivatives of 5-deazafolic acid, 5-deazaaminopterin, and 5-methyl-5-deazaaminopterin.
    Piper JR; Malik ND; Rhee MS; Galivan J; Sirotnak FM
    J Med Chem; 1992 Jan; 35(2):332-7. PubMed ID: 1732551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductase.
    Galivan J; Rhee MS; Johnson TB; Chou TC; Nair MG; Bunni M; Priest D
    Adv Enzyme Regul; 1989; 28():13-21. PubMed ID: 2624172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.